MW
Mark Wilterding sold $54K of RXST stock
Mark Wilterding, Chief Financial Officer of RxSight, Inc. (RXST), sold 7,765 shares of RXST stock worth $54K, per an SEC Form 4 filed Sep 3, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 31, 2026, 3 days before it was made public.
RXST has moved -39.0% since the trade date, from $7.33 to $4.47 (Nov 20, 2026 close).
- Traded
- Aug 31, 2026
- Disclosed
- Sep 3, 2026
- Filing delay
- 3 days
- Price since
- -39.0%
- Role
- Chief Financial Officer
- Source
- SEC Form 4